These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2656690

  • 1. Metalloendoprotease inhibitors which block the differentiation of L6 myoblasts inhibit insulin degradation by the endogenous insulin-degrading enzyme.
    Kayalar C, Wong WT.
    J Biol Chem; 1989 May 25; 264(15):8928-34. PubMed ID: 2656690
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors.
    Kayalar C, Wong WT, Hendrickson L.
    J Cell Biochem; 1990 Nov 25; 44(3):137-51. PubMed ID: 2269683
    [Abstract] [Full Text] [Related]

  • 3. Metalloendoprotease inhibitors that block fusion also prevent biochemical differentiation in L6 myoblasts.
    Baldwin E, Kayalar C.
    Proc Natl Acad Sci U S A; 1986 Nov 25; 83(21):8029-33. PubMed ID: 3534879
    [Abstract] [Full Text] [Related]

  • 4. Specific blockers of myoblast fusion inhibit a soluble and not the membrane-associated metalloendoprotease in myoblasts.
    Couch CB, Strittmatter WJ.
    J Biol Chem; 1984 May 10; 259(9):5396-9. PubMed ID: 6371004
    [Abstract] [Full Text] [Related]

  • 5. Correlation between fusion and the developmental regulation of membrane glycoproteins in L6 myoblasts.
    Rosenberg J, Szabo A, Rheuark D, Kayalar C.
    Proc Natl Acad Sci U S A; 1985 Dec 10; 82(24):8409-13. PubMed ID: 3909144
    [Abstract] [Full Text] [Related]

  • 6. The soluble metalloendoprotease required in myoblast fusion remains intracellular.
    Farach HA, Strittmatter WJ.
    Biochem Biophys Res Commun; 1987 Aug 31; 147(1):474-8. PubMed ID: 3307780
    [Abstract] [Full Text] [Related]

  • 7. Rat myoblast fusion requires metalloendoprotease activity.
    Couch CB, Strittmatter WJ.
    Cell; 1983 Jan 31; 32(1):257-65. PubMed ID: 6337722
    [Abstract] [Full Text] [Related]

  • 8. The development of insulin receptors and responsiveness is an early marker of differentiation in the muscle cell line L6.
    Beguinot F, Kahn CR, Moses AC, Smith RJ.
    Endocrinology; 1986 Jan 31; 118(1):446-55. PubMed ID: 3510122
    [Abstract] [Full Text] [Related]

  • 9. Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA.
    Rende M, Brizi E, Conner J, Treves S, Censier K, Provenzano C, Taglialatela G, Sanna PP, Donato R.
    Int J Dev Neurosci; 2000 Dec 31; 18(8):869-85. PubMed ID: 11154856
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor binding protein secretion by muscle cells: effect of cellular differentiation and proliferation.
    McCusker RH, Clemmons DR.
    J Cell Physiol; 1988 Dec 31; 137(3):505-12. PubMed ID: 2461381
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of the human type-1 insulin-like growth factor receptor in rat L6 myoblasts induces ligand-dependent cell proliferation and inhibition of differentiation.
    Quinn LS, Roh JS.
    Exp Cell Res; 1993 Oct 31; 208(2):504-8. PubMed ID: 8375479
    [Abstract] [Full Text] [Related]

  • 12. Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin.
    Duckworth WC, Hamel FG, Bennett R, Ryan MP, Roth RA.
    J Biol Chem; 1990 Feb 15; 265(5):2984-7. PubMed ID: 1689296
    [Abstract] [Full Text] [Related]

  • 13. Effects of metalloendoprotease inhibitors on insulin binding, internalization and processing in adipocytes.
    Jochen A, Berhanu P.
    Biochem Biophys Res Commun; 1987 Jan 15; 142(1):205-12. PubMed ID: 3545203
    [Abstract] [Full Text] [Related]

  • 14. Role of intracellular proteases in differentiation of L6 myoblast cells.
    Ebisui C, Tsujinaka T, Kido Y, Iijima S, Yano M, Shibata H, Tanaka T, Mori T.
    Biochem Mol Biol Int; 1994 Mar 15; 32(3):515-21. PubMed ID: 8032318
    [Abstract] [Full Text] [Related]

  • 15. Development regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells.
    Mitsumoto Y, Klip A.
    J Biol Chem; 1992 Mar 05; 267(7):4957-62. PubMed ID: 1311324
    [Abstract] [Full Text] [Related]

  • 16. Insulin degradation by human skeletal muscle.
    Neal GW, Kitabchi AE.
    Biochim Biophys Acta; 1982 Nov 24; 719(2):259-66. PubMed ID: 6758860
    [Abstract] [Full Text] [Related]

  • 17. [Kinetic studies of insulin degrading enzyme in cultured human lymphocytes].
    Yaso S.
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr 20; 64(4):289-302. PubMed ID: 3042472
    [Abstract] [Full Text] [Related]

  • 18. Properties of the lysosomal apparatus during differentiation of cultured striated muscle cells.
    McElligott MA, Roisen FJ, Keaton KS, Triemer DF, Li QS, St John AC, Yorke G, Bird JW.
    Acta Biol Med Ger; 1981 Apr 20; 40(10-11):1333-47. PubMed ID: 7043998
    [Abstract] [Full Text] [Related]

  • 19. The effect of protease inhibitors, leupeptin and E64d, on differentiation of C2C12 myoblasts in tissue culture.
    Kumar A, Shafiq S, Wadgaonkar R, Stracher A.
    Cell Mol Biol (Noisy-le-grand); 1992 Apr 20; 38(5-6):687-91. PubMed ID: 1483117
    [Abstract] [Full Text] [Related]

  • 20. The effect of protease inhibitors, leupeptin and E64d, on differentiation of C2C12 myoblasts in tissue culture.
    Kumar A, Shafiq S, Wadgaonkar R, Stracher A.
    Cell Mol Biol; 1992 Aug 20; 38(5):477-83. PubMed ID: 1468108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.